Barclays
ANGO icon

Barclays’s AngioDynamics ANGO Stock Holding History

Barclays’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1,500
Closed -$26K – 6903
2017
Q3 		$26K Hold
1,500
– – ﹤0.01% 5679
2017
Q2 		$24K Buy
+1,500
New +$23.7K ﹤0.01% 5695

Other funds holding ANGO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
BH
Broadfin Holdings Melville, New York $23.7M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WCM
Weber Capital Management San Francisco, California $118M AUM
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Barclays's ANGO Position: Q2 2026 in Review

Barclays reduced its AngioDynamics (ANGO) stake by 18% in Q2 2026, selling an estimated $81.6K and leaving 32,459 shares worth $422K. The position accounts for ﹤0.01% of the portfolio, ranked #3320.

Barclays first reported a position in ANGO in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.54M in Q3 2018. 161 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.

  • Barclays held 32,459 shares of AngioDynamics worth $422K as of Q2 2026.
  • Barclays sold 7,167 AngioDynamics shares in Q2 2026, an estimated $81.6K.
  • AngioDynamics made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #3320 holding.
  • Barclays first reported a position in AngioDynamics in Q2 2013 and has held it in 53 quarters since.
  • Barclays's AngioDynamics position peaked at $1.54M in Q3 2018.
  • 161 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.